rs55739947

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024652.6(LRRK1):​c.1246C>A​(p.Leu416Met) variant causes a missense change. The variant allele was found at a frequency of 0.0102 in 1,613,954 control chromosomes in the GnomAD database, including 112 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L416L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0086 ( 11 hom., cov: 31)
Exomes 𝑓: 0.010 ( 101 hom. )

Consequence

LRRK1
NM_024652.6 missense

Scores

1
7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.53

Publications

19 publications found
Variant links:
Genes affected
LRRK1 (HGNC:18608): (leucine rich repeat kinase 1) This gene encodes a multi-domain protein that is a leucine-rich repeat kinase and a GDP/GTP binding protein. The encoded protein is thought to play a role in the regulation of bone mass. Mice lacking a similar gene showed severe osteopetrosis, increased bone mineralization and decreased bone resorption. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068701804).
BP6
Variant 15-101010802-C-A is Benign according to our data. Variant chr15-101010802-C-A is described in ClinVar as Benign. ClinVar VariationId is 719736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00864 (1315/152260) while in subpopulation SAS AF = 0.0159 (77/4830). AF 95% confidence interval is 0.0131. There are 11 homozygotes in GnomAd4. There are 683 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRK1NM_024652.6 linkc.1246C>A p.Leu416Met missense_variant Exon 9 of 34 ENST00000388948.8 NP_078928.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRK1ENST00000388948.8 linkc.1246C>A p.Leu416Met missense_variant Exon 9 of 34 5 NM_024652.6 ENSP00000373600.3 Q38SD2-1
LRRK1ENST00000525284.5 linkn.1246C>A non_coding_transcript_exon_variant Exon 8 of 33 1 ENSP00000433069.1 E9PMK9
LRRK1ENST00000531270.5 linkn.1246C>A non_coding_transcript_exon_variant Exon 8 of 32 1 ENSP00000431668.1 E9PK39

Frequencies

GnomAD3 genomes
AF:
0.00861
AC:
1310
AN:
152140
Hom.:
10
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00249
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0129
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.00596
Gnomad SAS
AF:
0.0159
Gnomad FIN
AF:
0.0161
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00970
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00934
AC:
2330
AN:
249426
AF XY:
0.0100
show subpopulations
Gnomad AFR exome
AF:
0.00239
Gnomad AMR exome
AF:
0.00475
Gnomad ASJ exome
AF:
0.0119
Gnomad EAS exome
AF:
0.00507
Gnomad FIN exome
AF:
0.0134
Gnomad NFE exome
AF:
0.00940
Gnomad OTH exome
AF:
0.0115
GnomAD4 exome
AF:
0.0103
AC:
15109
AN:
1461694
Hom.:
101
Cov.:
34
AF XY:
0.0107
AC XY:
7753
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.00266
AC:
89
AN:
33472
American (AMR)
AF:
0.00568
AC:
254
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0116
AC:
302
AN:
26132
East Asian (EAS)
AF:
0.00710
AC:
282
AN:
39700
South Asian (SAS)
AF:
0.0154
AC:
1329
AN:
86222
European-Finnish (FIN)
AF:
0.0130
AC:
696
AN:
53410
Middle Eastern (MID)
AF:
0.0395
AC:
228
AN:
5768
European-Non Finnish (NFE)
AF:
0.0100
AC:
11172
AN:
1111904
Other (OTH)
AF:
0.0125
AC:
757
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
750
1500
2249
2999
3749
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00864
AC:
1315
AN:
152260
Hom.:
11
Cov.:
31
AF XY:
0.00917
AC XY:
683
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00248
AC:
103
AN:
41540
American (AMR)
AF:
0.0129
AC:
197
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3472
East Asian (EAS)
AF:
0.00598
AC:
31
AN:
5186
South Asian (SAS)
AF:
0.0159
AC:
77
AN:
4830
European-Finnish (FIN)
AF:
0.0161
AC:
171
AN:
10608
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00970
AC:
660
AN:
68012
Other (OTH)
AF:
0.0147
AC:
31
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
65
130
195
260
325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0100
Hom.:
18
Bravo
AF:
0.00794
TwinsUK
AF:
0.00971
AC:
36
ALSPAC
AF:
0.00804
AC:
31
ESP6500AA
AF:
0.00134
AC:
5
ESP6500EA
AF:
0.00949
AC:
78
ExAC
AF:
0.00853
AC:
1031
Asia WGS
AF:
0.0290
AC:
100
AN:
3478
EpiCase
AF:
0.0112
EpiControl
AF:
0.0107

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LRRK1-related disorder Benign:1
Feb 23, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.0069
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
4.5
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.29
Sift
Uncertain
0.017
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.68
MVP
0.72
MPC
1.2
ClinPred
0.019
T
GERP RS
2.0
Varity_R
0.24
gMVP
0.54
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55739947; hg19: chr15-101551007; COSMIC: COSV99033967; API